Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine

NCT02546752 is registered in ClinicalTrials.gov with Regenstrief Institute, Inc. as lead sponsor.

NCT NCT02546752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02546752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Lead sponsor
Regenstrief Institute, Inc.
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2015
Completion date
May 31, 2016
Enrollment
1,306 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, human papilloma virus infection type 11, human papilloma virus infection type 16, human papilloma virus infection type 18, human papilloma virus infection type 6